首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   190篇
  免费   12篇
  国内免费   3篇
妇产科学   2篇
基础医学   2篇
临床医学   8篇
内科学   16篇
皮肤病学   2篇
神经病学   5篇
特种医学   6篇
外科学   16篇
综合类   59篇
预防医学   7篇
眼科学   2篇
药学   11篇
中国医学   59篇
肿瘤学   10篇
  2023年   1篇
  2022年   3篇
  2021年   7篇
  2020年   7篇
  2019年   42篇
  2018年   30篇
  2017年   13篇
  2016年   8篇
  2015年   7篇
  2014年   14篇
  2013年   6篇
  2012年   8篇
  2011年   7篇
  2010年   16篇
  2009年   3篇
  2008年   5篇
  2007年   2篇
  2006年   3篇
  2005年   1篇
  2004年   2篇
  2003年   4篇
  2002年   2篇
  2001年   2篇
  2000年   2篇
  1999年   2篇
  1996年   1篇
  1995年   1篇
  1994年   1篇
  1992年   2篇
  1991年   1篇
  1978年   1篇
  1973年   1篇
排序方式: 共有205条查询结果,搜索用时 15 毫秒
201.

Background

The outcomes of living donor liver transplantation (LDLT) versus deceased donor liver transplantation (DDLT) for HCC patients were not well defined and it was necessary to reassess.

Methods

A comprehensive literature search was conducted in PubMed, Embase, Cochrane Library, Google Scholar and WanFang database for eligible studies. Perioperative and survival outcomes of HCC patients underwent LDLT were pooled and compared to those underwent DDLT.

Results

Twenty-nine studies with 5376 HCC patients were included. For HCC patients underwent LDLT and DDLT, there were comparable rates of overall survival (OS) (1-year, RR = 1.04, 95%CI = 1.00–1.09, P = 0.03; 3-year, RR = 1.03, 95%CI = 0.96–1.11, P = 0.39; 5-year, RR = 1.04, 95%CI = 0.95–1.13, P = 0.43), disease free survival (DFS) (1-year, RR = 1.00, 95%CI = 0.95–1.05, P = 0.99; 3-year, RR = 1.00, 95%CI = 0.94–1.08, P = 0.89; 5-year, RR = 1.01, 95%CI = 0.93–1.09, P = 0.85), recurrence (1-year, RR = 1.41, 95%CI = 0.72–2.77, P = 0.32; 3-year, RR = 0.89, 95%CI = 0.57–1.39, P = 0.60; and 5-year, RR = 0.85, 95%CI = 0.56–1.31, P = 0.47), perioperative mortality within 3 months (RR = 0.89, 95%CI = 0.50–1.59, p = 0.70) and postoperative complication (RR = 0.99, 95%CI = 0.70–1.39, P = 0.94). LDLT was associated with better 5-year intention-to-treat patient survival (ITT-OS) than DDLT (RR = 1.11, 95% CI = 1.01–1.22, P = 0.04).

Conclusion

This meta-analysis suggested that LDLT was not inferior to DDLT in consideration of comparable perioperative and survival outcomes. However, in terms of 5-year ITT-OS, LDLT was a possibly better choice for HCC patients.  相似文献   
202.

Background

As intrapancreatic accessory spleen (IPAS) is rarely encountered during clinical practice, the aim of this review was to summarize the epidemiologic features, the diagnosis and treatment of IPAS.

Methods

MEDLINE and EMBASE were searched for articles reporting on IPAS. Categorical variables were reported as frequency and percentage. Continuous variables were reported as median (range).

Results

A total of 105 patients were included, of which 73% were detected incidentally. The male/female ratio was 1.23. The size of IPAS in patients who had previously undergone splenectomy was larger than that of patients without prior splenectomy (2.5 cm vs 1.5 cm; p = 0.020). No preoperative examination was able to make a definite diagnosis for all IPASs. More than half of the patients (55%) received surgical treatment, most of which (87%) were suspected as pancreatic neuroendocrine tumors (p-net) preoperatively.

Conclusions

Although rare, IPAS should be considered in the differential of patients with suspected incidental p-net, especially if there has been a past history of splenectomy. Preoperative diagnosis is important as unnecessary surgery can be avoided. As it is difficult to make a definite diagnosis of IPAS by one single examination, multiple techniques may be required.  相似文献   
203.
ObjectivesFear of falling (FOF) is common in older adults. We investigated whether FOF affects development of cognitive decline over a 3-year period in community-dwelling older adults with intact cognition.DesignRetrospective, cohort, observational.Setting and participantsData for 4280 older adults with normal cognition at baseline from the Survey of Living Conditions and Welfare Needs of Korean Older Persons (2008 and 2011).MethodsHistory of falls and severity of FOF (no fear, somewhat fearful, or very fearful) were assessed at baseline (2008). We evaluated cognitive function using the Korean version of the Mini-Mental State Examination in 2008 and 2011, and defined cognitive decline as a decrease of ≥3 points over the 3-year study period. Multivariable logistic regression analysis was performed to examine the association between FOF and cognitive decline.ResultsThe prevalence of being somewhat fearful of falling was 54.6% and that of being very fearful was 9.7%. The participants who were somewhat fearful of falling had a 1.2-fold higher risk of cognitive decline; this finding lost significance in adjusted models. The participants who were very fearful of falling had a 1.45-fold higher risk of cognitive decline than those with no FOF after adjusting for confounders [odds ratio (OR) 1.45, 95% confidence interval (CI) 1.08–1.95]. When we divided the participants according to age, sex, and baseline cognitive function, the association was significant in men (OR 2.29, 95% CI 1.24–4.25), participants age >70 years (OR 1.57, 95% CI 1.06–2.33), and those with a Mini-Mental State Examination score <30 (OR 1.45, 95% CI 1.07–1.98).Conclusions and implicationsBeing very fearful of falling increased the risk of cognitive decline in older Korean adults. Physicians should be aware of the risk of development of cognitive impairment in older individuals with FOF.  相似文献   
204.
结合中医传统经典理论,参考相关流派及各医家的不同观点,结合多年跟师体悟,整理郭蓉娟教授发表的论文和著作,归纳总结其治疗情志病的经验和遣方用药规律。在接诊情志病患者时,导师注重审症求因,借助现代医疗手段精准定位,推行叙事医学理念与平行病历的书写。在情志病治疗方面,导师提倡心身并调,结合现代心理学方法进行语言疏导和认知重构,临证用药不拘泥于单一脏腑,将调畅全身气机贯穿治疗始终,并身体力行中西医结合,优势互补。在情志病防治方面,导师认为应未病先防,既病防变,调理脾胃为治疗之本,擅于重用生黄芪。郭蓉娟教授治疗情志病经验丰富,以治未病思想为主导,古今结合,心身并调,脾胃为本,特色鲜明,疗效显著,其经验值得进一步挖掘和传承。  相似文献   
205.
<正>慢加急性肝衰竭(acute-on-chronic liver failure,ACLF)是指在慢性肝脏疾病的基础上,由各种诱因引起以急性黄疸加深、凝血功能障碍为肝衰竭表现的综合征,属于中医“急黄”“瘟黄”等范畴[1]。ACLF是我国最常见的肝衰竭亚型,短期死亡率高,治疗难度大,目前仍缺乏特异性的治疗手段。中西医结合治疗在改善症状、提高患者生存率等方面具有独特的疗效及优势。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号